GRIFOLS | GRF - Current Liabilities

Stock Price
8.95
Daily Change
0 0%
Monthly
-0.11%
Yearly
5.12%
Q2 Forecast
8.72

GRIFOLS reported EUR2.02B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alcon AG USD 3.05B 59M Dec/2025
Almirall EUR 350.64M 52.12M Dec/2025
Amadeus IT EUR 3.03B 149.5M Dec/2025
Amarin USD 194.46M 12.23M Dec/2025
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Cie Automotive EUR 1.92B 8.97M Dec/2025
Demant DKK 7.42B 1.63B Dec/2025
Ence Energia y Celulosa EUR 435.03M 5.93M Dec/2025
Essilor EUR 12.15B 766M Dec/2025
Ferrovial EUR 6.46B 486M Dec/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 6.25B 485.68M Dec/2025
Galapagos EUR 152.86M 213.7M Dec/2025
Genmab DKK 1.43B 686M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.02B 135.85M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Inditex EUR 10.17B 3.24B Dec/2025
Merck EUR 9.04B 405M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Philips EUR 7.51B 479M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Smith & Nephew USD 1.54B 236M Dec/2025
UCB EUR 4.4B 470M Dec/2025
Viscofan EUR 437.49M 43.64M Mar/2026